van Dongen JJM - Search Results

1

Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples.

van der Velden VHJ, Flores-Montero J, Perez-Andres M, Martin-Ayuso M, Crespo O, Blanco E, Kalina T, Philippé J, Bonroy C, de Bie M, Te Marvelde J, Teodosio C, Corral Mateos A, Kanderová V, van der Burg M, Van Hoof D, van Dongen JJM, Orfao A. van der Velden VHJ, et al. Among authors: van dongen jjm, van hoof d, van der burg m. J Immunol Methods. 2019 Dec;475:112287. doi: 10.1016/j.jim.2017.03.011. Epub 2017 Mar 22. J Immunol Methods. 2019. PMID: 28341440 Free article.

2

Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.

Szczepanski T, van der Velden VH, Hoogeveen PG, de Bie M, Jacobs DC, van Wering ER, van Dongen JJ. Szczepanski T, et al. Blood. 2004 May 15;103(10):3798-804. doi: 10.1182/blood-2003-08-2952. Epub 2003 Dec 4. Blood. 2004. PMID: 14656882 Free article.

3

Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression.

van Zelm MC, van der Burg M, de Ridder D, Barendregt BH, de Haas EF, Reinders MJ, Lankester AC, Révész T, Staal FJ, van Dongen JJ. van Zelm MC, et al. J Immunol. 2005 Nov 1;175(9):5912-22. doi: 10.4049/jimmunol.175.9.5912. J Immunol. 2005. PMID: 16237084

4

Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease.

van der Velden VH, de Bie M, van Wering ER, van Dongen JJ. van der Velden VH, et al. Haematologica. 2006 May;91(5):679-82. Epub 2006 Apr 19. Haematologica. 2006. PMID: 16627258

5

Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia.

van der Velden VH, Hoogeveen PG, Pieters R, van Dongen JJ. van der Velden VH, et al. Br J Haematol. 2006 May;133(4):382-8. doi: 10.1111/j.1365-2141.2006.06056.x. Br J Haematol. 2006. PMID: 16643444 Free article.

6

An antibody-deficiency syndrome due to mutations in the CD19 gene.

van Zelm MC, Reisli I, van der Burg M, Castaño D, van Noesel CJ, van Tol MJ, Woellner C, Grimbacher B, Patiño PJ, van Dongen JJ, Franco JL. van Zelm MC, et al. N Engl J Med. 2006 May 4;354(18):1901-12. doi: 10.1056/NEJMoa051568. N Engl J Med. 2006. PMID: 16672701 Free article.

7

Flow-cytometric immunophenotyping of normal and malignant lymphocytes.

Szczepański T, van der Velden VH, van Dongen JJ. Szczepański T, et al. Clin Chem Lab Med. 2006;44(7):775-96. doi: 10.1515/CCLM.2006.146. Clin Chem Lab Med. 2006. PMID: 16776621 Review.

8

B-cell recovery after stem cell transplantation of Artemis-deficient SCID requires elimination of autologous bone marrow precursor-B-cells.

van der Burg M, Weemaes CM, Preijers F, Brons P, Barendregt BH, van Tol MJ, Hoogerbrugge P, van Dongen JJ. van der Burg M, et al. Haematologica. 2006 Dec;91(12):1705-9. Haematologica. 2006. PMID: 17145611

9

Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion.

van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. van Zelm MC, et al. J Exp Med. 2007 Mar 19;204(3):645-55. doi: 10.1084/jem.20060964. Epub 2007 Feb 20. J Exp Med. 2007. PMID: 17312005 Free PMC article.

10

New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.

Pike-Overzet K, van der Burg M, Wagemaker G, van Dongen JJ, Staal FJ. Pike-Overzet K, et al. Mol Ther. 2007 Nov;15(11):1910-6. doi: 10.1038/sj.mt.6300297. Epub 2007 Aug 28. Mol Ther. 2007. PMID: 17726455 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page